Another positive development for Lilly's weight-loss portfolio, with the company reporting positive results from its Phase 3 trial of a once-daily oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist. …
Lilly records another win in weight loss in trial of oral GLP-1 agonist
April 22, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Radiopharm Theranostics reports Preclinical Lu177-B7H3-mAb data
June 2, 2025 - - Australian Biotech -
Neurotech announces positive human PK study results for NTI164
June 2, 2025 - - Australian Biotech -
Cardiex receives TGA approval for CONNEQT Pulse arterial health monitor
June 2, 2025 - - Australian Biotech -
Pharmac minister sworn in as New Zealand's Deputy Prime Minister
June 1, 2025 - - Latest News -
An opportunity for reflection on the need to humanise PBS decision-making
June 1, 2025 - - Latest News -
Ipsen's Julien Dagher promoted to European leadership role
June 1, 2025 - - Latest News -
Daiichi Sankyo secures certification as Great Place to Work
June 1, 2025 - - Latest News